Buy K/Lyte Fruit from Discount Pharmacy
We are a leading Canadian mail-order pharmacy service focusing on both on prescription cost-containment and patient safety. We only work with a small network of trusted and reputable international pharmacies and fulfillment centers, giving you access to authentic medications at low prices every day. All medications are shipped directly to you from our affiliated licensed international and Canadian pharmacies and fulfillment centers. Our staff are knowledgeable and efficient to ensure that your shopping experience is hassle free. Save on prescription drugs like K/Lyte Fruit as well as other prescription drugs like Abilify, Avapro, Effexor, Gleevec, Nuvigil, Prevacid, Protonix, Levitra, Valtrex, Zocor.
10 Great Reasons to Choose Our Service!
Live and professional customer service ready to help you order K/Lyte Fruit.
Your prescription drugs are mailed directly to your home from our licensed Canadian pharmacy in Canada.
Fully insured packages for shipping from a licensed pharmacy.
Live, friendly, and knowledgeable customer service helping you order your prescription.
The exchange rate between the American currency and Canadian dollar allows American more spending power when buying from Canada.
Orders placed with our Canadian Pharmacy are reviewed by fully licensed Canadian physicians and fully licensed Canadian pharmacists.
Prompt and efficient service from our Canadian pharmacy means your prescription drugs will be delivered in 2-3 weeks from the time your prescription order is received.
The Canadian government regulates the price of prescription drugs in Canada so you can save hundreds of dollars per year.
Many towns, cities and states are encouraging their citizens to consider buying their prescription medications from International pharmacies.
Why Are Cancer Drugs So Expensive?
The high cost of cancer drugs is related to a number of factors. It is very very expensive to move findings from bench to bedside and to perform all the regulatory studies (from phase 1, 2, and 3 clinical trials) to gain approval. Second, even when the monopoly is broken with the arrival of 'new and improved' versions of an approved drug, the older drug (and by now generic) tends to be viewed as substandard treatment, thereby perpetuating the situation. Third, the very nature of cancer, and the seriousness of the diagnosis, plays a role in that patients and physicians are often willing to pay the high price of treatment even for marginal improvements in outcome. Finally, because most cancers are incurable, patients are treated with each approved agent creating a virtual monopoly because the use of one drug does not automatically mean that the others are no longer needed.